Insights
Insights From Our Experts
Articles
Case Study: Increasing Product Adoption Rate through EVERSANA’s Digital Hub Portal
Problem: Our client launched a new product in the U.S. market, but initial adoption rates were disappointingly low. Physicians, who were eager to incorporate this innovative product into their practice, hesitated to prescribe from the complexity…
Evaluating Talazoparib Plus Enzalutamide Against Standard of Care Therapies in Metastatic Castration-Resistant Prostate Cancer: A Matching-Adjusted Indirect Comparison
Posted by Imtiaz Samjoo , Anja Haltner, MSc , Samantha Craigie , Sarah Walsh on March 27, 20253/27/25
Metastatic castration-resistant prostate cancer (mCRPC) is an incurable condition associated with poor prognosis and reduced quality of life. Historically, treatment options were limited, and despite recent advancements, the five-year survival rate for metastatic prostate cancer remains…
Optimizing Specialty Pharmacy Networks: A Best-in-Class Approach for Rare Disease Therapies
For manufacturers of rare disease therapies, selecting the right specialty pharmacy model is a crucial decision that directly impacts patient access, adherence and overall brand success. An exclusive specialty pharmacy model offers distinct advantages, including streamlined…
The End of the Blockbuster: Adapting to a New Pharmaceutical Landscape With a New Commercialization Model
Traditional commercialization strategies that once fueled massive growth and profitability are no longer viable in today’s complex and competitive market. High SG&A costs without resulting revenue, patent cliffs, rising patient acquisition costs, convoluted supply chain management,…
EVERSANA Wins AI Excellence Award for 4th Straight Year, Building on Legacy of Innovation
Company recognized in 2025 for AI-Powered HCP Panels Used for Sales Representative Training Innovation is in the lifeblood of EVERSANA. And so, when the 2025 AI Excellence Awards winners were announced, it was not surprising that…
Capital Efficient Commercialization: A New Model for Success
In today’s fiscal environment, efficient capital allocation is crucial for success. Biopharma companies can take advantage of new approaches to commercialization to dramatically reduce the capital burden to launch their products. Building Your Own Commercial Infrastructure…
Boosting Pharma Efficiency: A New Model for Asset Value Retention
In the pharmaceutical industry, maintaining asset value is challenging. Traditionally, companies either licensed their products or built their own commercial setup, each option with its own risks. But what if there were a powerful alternative that…
Overcoming the Odds: How EVERSANA Helped a Family Navigate Their Rare Disease Journey
A Rare Diagnosis and the Start of a Family’s Courageous Journey For families navigating the complexities of a rare disease diagnosis, the path can be filled with uncertainty, challenges and moments of profound resilience. One such…
Maximizing Sales with AI: A Strategic Roadmap for Success
Artificial intelligence (AI) is transforming the sales landscape, offering innovative ways to boost efficiency, enhance decision-making and drive revenue growth. With AI adoption in sales ranking among the top three functions across industries, organizations must leverage…
Rare Disease Care in India: A Path to Positive Impact
India’s rare disease market is on the rise, expected to grow from $2.74 billion to $6.6 billion by 2030. However, challenges such as delayed diagnoses, limited treatment accessibility and underutilized government funds continue to impact patient…